A. “Neuronal LR11 Expression Does Not Differentiate between Clinically-Defined Alzheimer’s Disease and Control Brains,” by Kristen L. Sager, Joanne Wuu, Jeremy H. Herskowitz, Elliott J. Mufson, Allan I. Levey, and James J. Lah (PLoS ONE 7(8): e40527. doi:10.1371/journal.pone.0040527, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0040527
B. “Copper Chelator Induced Efficient Episodic Memory Recovery in a Non-Transgenic Alzheimer’s Mouse Model,” by Johnatan Ceccom, Frederic Cosledan, Helene Halley, Bernard Frances, Jean Michel Lassalle, and Bernard Meunier (PLoS ONE 7(8): e43105. doi:10.1371/journal.pone.0043105, XML, HTML, and .pdf format, 7p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043105
C. “Amyloid-{beta} Peptide Binds to Cytochrome C Oxidase Subunit 1,” by Luis Fernando Hernandez-Zimbron, Jose Luna-Munoz, Raul Mena, Raul Mena, Ricardo Vazquez-Ramirez, Carlos Kubli-Garfias, David H. Cribbs, Karen Manoutcharian, and Goar Gevorkian (PLoS ONE 7(8): e42344. doi:10.1371/journal.pone.0042344, XML, HTML, and .pdf format, 9p.).
www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042344
